Why the study?
Do therapeutic interventions that control glomerular capillary hypertension prevent progressive renal injury compared to therapies that only control systemic hypertension?
Do therapeutic interventions that control glomerular capillary hypertension prevent progressive renal injury compared to therapies that only control systemic hypertension?
This review highlights that antihypertensive therapy must specifically control intraglomerular hypertension to effectively prevent the progression of renal injury.
Answers are grounded in this paper and cite their sources.
Systemic BP control alone may not halt renal progression; leaves open whether intraglomerular-targeted therapies improve outcomes in trials.
Systemic hypertension is both cause and consequence of progressive renal disease. Recent experimental studies indicate that systemic and glomerular capillary hypertension are not necessarily accompaniments, and that therapeutic interventions may affect systemic and glomerular pressures independently. Therapeutic interventions that control glomerular capillary hypertension protect against progressive renal injury, even in the presence of continued systemic hypertension. Conversely, therapy that controls systemic but not glomerular hypertension does not protect the kidney from continuing damage. Thus, control of intraglomerular hypertension is necessary if antihypertensive therapy is to be effective in preventing progression of renal injury.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: